David Niklas Springer (David N Springer, David Springer)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Epidermal Growth Factor Receptor

Structural Basis

Angiotensin Converting Enzyme

Top Venues

Diagnostics (Basel, Switzerland)

Clinical chemistry and laboratory medicine

This page only lists publications with an associated author ORCID identifier.

Publications

David Niklas Springer, Eva Höltl, Katja Prüger, Elisabeth Puchhammer-Stöckl, Judith Helene Aberle, Karin Stiasny, Lukas Weseslindtner
Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray. Vaccines 12 (1) (2024)
David Niklas Springer, Eva Höltl, Katja Prüger, Elisabeth Puchhammer-Stöckl, Judith Helene Aberle, Karin Stiasny, Lukas Weseslindtner
Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray. Vaccines 12 (1) (2024)
David Niklas Springer, Eva Höltl, Katja Prüger, Elisabeth Puchhammer-Stöckl, Judith Helene Aberle, Karin Stiasny, Lukas Weseslindtner
Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray. Vaccines 12 (1) (2024)
David Niklas Springer, Simon Daller, Michael Knappik, Katja Prüger, Sylvia Hartl, Robab Breyer-Kohansal, Elisabeth Puchhammer-Stöckl, Judith Helene Aberle, Lukas Weseslindtner, Marie Kathrin Breyer
A Multivariant Surrogate Virus Neutralization Test Demonstrates Distinct SARS-CoV-2-Specific Antibody Responses in People Living with HIV after a Fourth Monovalent mRNA Vaccination or an Omicron Breakthrough Infection. Diagnostics (Basel, Switzerland) 14 (8) (2024)
David Niklas Springer, Simon Daller, Michael Knappik, Katja Prüger, Sylvia Hartl, Robab Breyer-Kohansal, Elisabeth Puchhammer-Stöckl, Judith Helene Aberle, Lukas Weseslindtner, Marie Kathrin Breyer
A Multivariant Surrogate Virus Neutralization Test Demonstrates Distinct SARS-CoV-2-Specific Antibody Responses in People Living with HIV after a Fourth Monovalent mRNA Vaccination or an Omicron Breakthrough Infection. Diagnostics (Basel, Switzerland) 14 (8) (2024)
David Niklas Springer, Simon Daller, Michael Knappik, Katja Prüger, Sylvia Hartl, Robab Breyer-Kohansal, Elisabeth Puchhammer-Stöckl, Judith Helene Aberle, Lukas Weseslindtner, Marie Kathrin Breyer
A Multivariant Surrogate Virus Neutralization Test Demonstrates Distinct SARS-CoV-2-Specific Antibody Responses in People Living with HIV after a Fourth Monovalent mRNA Vaccination or an Omicron Breakthrough Infection. Diagnostics (Basel, Switzerland) 14 (8) (2024)
Christoph Buchta, David Niklas Springer, Jovana Jovanovic, Christian Borsodi, Lisa Weidner, Nazanin Sareban, Ulla Radler, Mathias M Müller, Andrea Griesmacher, Elisabeth Puchhammer-Stöckl, Thomas Wagner, Christof Jungbauer, Karin Stiasny, Lukas Weseslindtner
Three rounds of a national external quality assessment reveal a link between disharmonic anti-SARS-CoV-2 antibody quantifications and the infection stage. Clinical chemistry and laboratory medicine (2023)
David Niklas Springer, Michael Bauer, Iris Medits, Jeremy V Camp, Stephan W Aberle, Clemens Burtscher, Eva Höltl, Lukas Weseslindtner, Karin Stiasny, Judith Helene Aberle
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants. NPJ vaccines 8 (1) (2023)
David Niklas Springer, Marianna Traugott, Elisabeth Reuberger, Klaus Benjamin Kothbauer, Christian Borsodi, Michelle Nägeli, Theresa Oelschlägel, Hasan Kelani, Oliver Lammel, Josef Deutsch, Elisabeth Puchhammer-Stöckl, Eva Höltl, Judith Helene Aberle, Karin Stiasny, Lukas Weseslindtner
A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection. Diagnostics (Basel, Switzerland) 13 (13) (2023)